Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5676513 | American Journal of Obstetrics and Gynecology | 2016 | 29 Pages |
Abstract
Bupropion and its active metabolites cross the placenta to the fetal circulation. The concentrations of hydroxybupropion and threohydrobupropion in umbilical cord venous plasma were higher than bupropion concentrations suggesting a higher fetal exposure to the metabolites than the parent drug. The higher levels of threohydrobupropion in the amniotic fluid than those in umbilical cord venous plasma suggest that enzymes involved in the metabolism of bupropion to threohydrobupropion are most likely active in the fetus. The biological consequences of fetal exposure to maternally administered bupropion and/or its active metabolites via placental transfer and recirculation of the amniotic fluid are yet to be determined.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Valentina M. BS, Holly DHEd, Cheryl MD, Shannon M. MD, Mahmoud S. PhD, Gary D.V. MD, Tatiana N. PhD,